Dec 8 2017 Hemogenyx Pharmaceuticals are creating blood cancer treatments with US$9 billion market potential London South East
Dec 7 2017 Hemogenyx Pharmaceuticals happy with progress and recent collaborations Proactive Investors
Nov 27 2017 Small Cap Share Ideas: Pioneering Biotech Firm Hemogenyx Pharmaceuticals Set To Transform Treatment Of Blood Cancer Mail Online
Nov 20 2017 Top 10 Biotech Companies That Are Pushing The Envelope In The Medical Field Keeping Stock
Oct 12 2017 Hemogenyx Pharmaceuticals Aims For Revolution In Blood Cancer Treatment Proactive Investors
Oct 9 2017 Hemogenyx Pharmaceuticals Launching Products That Could Treat Bone Marrow Transplants Without Chemotherapy IB Times
Cell CyberneticsCell Cybernetics